The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer
Authors
Keywords
Cervical cancer, Radiotherapy, Squamous cell carcinoma antigen
Journal
Radiation Oncology
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-15
DOI
10.1186/s13014-019-1355-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis
- (2018) Chuenkamon Charakorn et al. GYNECOLOGIC ONCOLOGY
- Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage
- (2018) Fan Xu et al. Journal of Cancer
- Image-guided, intensity-modulated radiation therapy in definitive radiotherapy for 1433 patients with cervical cancer
- (2018) Weiping Wang et al. GYNECOLOGIC ONCOLOGY
- Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy
- (2018) Weiping Wang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Validation of the 2018 FIGO cervical cancer staging system
- (2018) Koji Matsuo et al. GYNECOLOGIC ONCOLOGY
- Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy
- (2018) Ke Hu et al. Radiation Oncology
- Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer
- (2017) Ja Young Kim et al. GYNECOLOGIC ONCOLOGY
- Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01
- (2017) Jong Hoon Lee et al. GYNECOLOGIC ONCOLOGY
- Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma
- (2017) Huilun Yang et al. International Journal of Clinical Oncology
- The Predictive Value of Tumor Size, Volume, and Markers During Radiation Therapy in Patients With Cervical Cancer
- (2017) Kyu Chan Lee et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis
- (2017) Dianbo Xu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence
- (2016) Michela Salvatici et al. GYNECOLOGIC ONCOLOGY
- A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes
- (2016) Seiji Mabuchi et al. GYNECOLOGIC ONCOLOGY
- Complementary Roles of Squamous Cell Carcinoma Antigen and 18F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
- (2015) Ying-Ying Hu et al. Journal of Cancer
- Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy
- (2013) Ryuji Kawaguchi et al. Journal of Gynecologic Oncology
- Risk Assessment Tool for Distant Recurrence After Platinum-Based Concurrent Chemoradiation in Patients With Locally Advanced Cervical Cancer: A Korean Gynecologic Oncology Group Study
- (2012) Sokbom Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix
- (2012) Eng-Yen Huang et al. Radiation Oncology
- Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations
- (2011) Ritu Salani et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
- (2011) Alfonso Dueñas-González et al. JOURNAL OF CLINICAL ONCOLOGY
- Burden of cervical cancer in the United States, 1998-2003
- (2010) Meg Watson et al. CANCER
- Prognostic Utility of Squamous Cell Carcinoma Antigen in Carcinoma of the Cervix: Association With Pre- and Posttreatment FDG-PET
- (2010) Jeffrey R. Olsen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy
- (2010) Sang Yoon et al. Radiation Oncology
- Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells
- (2009) Keng-Fu Hsu et al. Autophagy
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now